The Engineer - UK trial aims to pinpoint those at risk of sudden cardiac arrest

A UK trial is underway to ascertain which patients will benefit from an implantable cardioverter defibrillator (ICD), some of which are fitted unnecessarily at a cost to the NHS.

Related Keywords

London ,City Of ,United Kingdom ,British ,Phil Odonoghue ,Nick Curzen ,Nilesh Samani ,Andrew Flett ,University Hospital Southampton ,British Heart Foundation ,Philo Donoghue ,Professor Nick Curzen ,Clinical Trials ,University Hospital ,Sir Nilesh Samani ,East Kent ,